- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
Latest Health_Medical_Pharma Items
Etta James' manager says the terminally ill blues singer is breathing on her own after being taken off a respirator.
New registered nurses would have to earn bachelor's degrees within 10 years to keep working in New York under a bill lawmakers are considering as part of a national push to raise educational standards for nurses, even as the health care industry faces staffing shortages.
A man from Cape Cod is the first person on record to contract rabies in Massachusetts in more than 75 years, state public health officials said Friday.
Attorney Colleen Gorman has a holiday ritual that doesn't involve buying presents or counting down to midnight: She goes online to look for new hangover remedies she hasn't tried.
In a story Dec. 27 about state efforts around the country to reduce Medicaid costs, The Associated Press reported erroneously that New Jersey Gov. Chris Christie is pushing a plan that would mean a parent of two making more than $103 a week would no longer be eligible for coverage. Such an option had been under consideration but was rejected.
Starting in 2012, the government will charge a new fee to your health insurance plan for research to find out which drugs, medical procedures, tests and treatments work best. But what will Americans do with the answers?
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.
Rosalia Adhiambo won't take the free anti-HIV drugs that would prolong her life. The spiraling price of food in Kenya means she can't afford to feed both her grandniece and herself.
Bill Dunphy thought his colonoscopy would be free.